Yasheng’s AI-Powered Cancer Therapy Patent Revolutionizes Immunotherapy Development
Yasheng Group,an agricultural and biotech company with U.S. headquarters in San Jose, California announced that HERB filed for patent protection with the USPTO. The invention relates to the use of artificial intelligence (AI) to improve cancer immunotherapy. The provisionally patented technology aims to use AI in various aspects of immunotherapy development,
Recommended AI News: LiveRamp Embedded Identity is Now Available in the Snowflake Media Data Cloud
including antigen characterizations, AI-based immune signatures, prediction of immunotherapy responses, manufacturing optimization, and AI assistance in clinical trials. AI can assist in identifying antigens and binding sites for CAR T-cell therapies, characterizing the tumor-immune microenvironment, and predicting immunotherapy responses. It can also optimize the manufacturing process of CAR-T and CAR-NK cell therapies, reducing time and costs and improving clinical success rates. The invention’s unique features include the use of AI in multiple aspects of immunotherapy development, which has the potential to improve diagnostic accuracy, optimize treatment planning, predict outcomes of care, and reduce human resource costs.
Recommended AI News: Red Hat Helps Türk Telekom Digitally Transform Across its Business to the Edge
Yasheng Group
Yasheng Group (“The Company”) is a Colorado corporation that conducts business operations in US, China, and the Philippines in four major segments: Agriculture, Mining, Biotechnology, and Blockchain + IoT. The company’s agriculture products include herbal medicine, herbal organic food, ginkgo, solarium, betel nut, coconut, coffee, wolfberry. Its products are exported to 15 countries around the world and 2875 Cooperative regional distribution agents. It also designs, develops, and markets new technologies related to agriculture and genetic biology.
Recommended AI News: Tafi Partners with Coca-Cola to Bring a Taste of Space to Samsung AR Emoji with New Digital Apparel Collection
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.